DAP12 Antibodies

Santa Cruz Biotechnology features a diverse variety of DAP12 monoclonal antibodies for research focused on understanding DAP12's role in immune signaling pathways. DAP12 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DAP12, also known as TYROBP, is an adaptor protein that plays a crucial role in the activation of immune cells, particularly in the signaling pathways of myeloid and natural killer (NK) cells. Research has shown that DAP12 is essential for the regulation of immune responses and has been implicated in various diseases, including autoimmune disorders and cancer. Understanding DAP12's molecular mechanisms and interactions provides valuable insights into immune system function and regulation. Investigating DAP12's role in cellular signaling pathways can reveal new therapeutic targets for immune-related conditions. Exploring DAP12's involvement in disease progression helps advance our understanding of pathological processes. Current research continues to uncover new aspects of DAP12's function in both healthy and diseased states. Santa Cruz Biotechnology monoclonal antibodies for DAP12 enable researchers to make meaningful contributions to immunological research and therapeutic development.